The MG Cyberster is India’s first all-electric roadster, with futuristic design with advanced technology. The car features electric scissor doors, equipped with dual radar sensors for safety, and an ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

Some parents say that red dye No. 3 in foods causes behavioral problems in their kids. (Photo illustration: Celina Pereira for Yahoo News; photos: Getty Images) ...

ABU DHABI, 6th June, 2017 (WAM) -- The UAE Ministry of Health and Prevention has issued a circular to all medical facilities and hospitals to withdraw Brilinta 90 mg batch number JB504 by AstraZeneca ...

The FTC turned a spotlight on “excess” price hikes on specialty generic drugs for cancer, heart disease, HIV and other conditions.

The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry ... The agency’s report found that the “Big 3 PBMs” – CVS Health’s ...

“A facelift for the Model 3 comes just in the nick of time to nudge it back ahead of rivals” There can’t be anyone who doesn’t know what a Tesla is: it’s incredible how the startup ...

NEWS10 went on an exclusive ride along with the sheriff’s office in November 2024 while police conducted a drug sting. Following the execution of a search warrant at a 6th Avenue home ...

The 41.9 kWh battery pack in Chevrolet Spark EUV spied testing, is rated to deliver around 400 km on a single charge (CLTC cycle) You might be familiar with the Yep 3-Door and Yep Plus 5-Door ...

Neu­ro­science drug de­vel­op­er Neumo­ra Ther­a­peu­tics re­leased high­ly an­tic­i­pat­ed re­sults from the first of three Phase 3 tri­als for its ex­per­i­men­tal ma­jor … ...

The first of three late-stage readouts on Neumora’s lead drug candidate has ended in failure ... the first of three phase 3 trials of navacaprant in major depressive disorder.

(NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study of navacaprant ... in particular the contrast in drug and placebo responses in depressed mood ...